High-affinity block of voltage-operated rat IIA neuronal sodium channels by 2,6 di-tert-butylphenol, a propofol analogue.
G Haeseler, M Leuwer
Index: Eur. J. Anaesthesiol. 20(3) , 220-4, (2003)
Full Text: HTML
Abstract
Propofol is a phenol derivative (2,6 di-isopropylphenol) with a unique effect profile including activating effects on GABA(A) and blocking effects on voltage-operated sodium channels. If the substituents in the 2- and the 6-positions are replaced by tert-butyl groups, the resulting phenol derivative, 2,6 di-tert-butylphenol, despite being a close structural propofol analogue, completely lacks GABA(A) receptor effects. The aim of this in vitro study was to investigate the effects of 2,6 di-tert-butylphenol on voltage-operated neuronal sodium channels in order to determine whether and, if so, how these structural changes alter the sodium channel-blocking effect seen with propofol.Whole-cell sodium inward currents through heterologously expressed rat type IIA sodium channels were recorded in the absence and presence of definite concentrations of 2,6 di-tert-butylphenol and propofol.When applied at concentrations > or = 30 micromol, 2,6 di-tert-butylphenol completely and irreversibly blocked sodium inward currents. The blockade equilibrium time was about 2 min. A partial washout was possible only if the application was stopped before the equilibrium of the blockade was achieved.2,6 Di-tert-butylphenol exerts a high-affinity block of neuronal sodium channels. Apparently, the slight structural differences of 2,6 di-tert-butylphenol in comparison with propofol--which account for the lack of GABA(A) receptor effects--enhance its voltage-operated sodium channel-blocking effects. As 2,6 di-tert-butylphenol is much more potent than most sodium channel blockers in clinical use, it might be of interest in the development of local anaesthetics.
Related Compounds
Related Articles:
2005-11-17
[J. Med. Chem. 48 , 7234-42, (2005)]
2009-04-15
[Bioorg. Med. Chem. 17 , 3207-11, (2009)]
Antioxidant activity of propofol and related monomeric and dimeric compounds.
2005-03-01
[Chem. Pharm. Bull. 53(3) , 344-6, (2005)]
1996-02-01
[Dokl. Akad. Nauk. 346(5) , 705-7, (1996)]
1987-06-01
[Lipids 22(6) , 401-8, (1987)]